JP2018515612A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515612A5
JP2018515612A5 JP2018511333A JP2018511333A JP2018515612A5 JP 2018515612 A5 JP2018515612 A5 JP 2018515612A5 JP 2018511333 A JP2018511333 A JP 2018511333A JP 2018511333 A JP2018511333 A JP 2018511333A JP 2018515612 A5 JP2018515612 A5 JP 2018515612A5
Authority
JP
Japan
Prior art keywords
methyl
quinoxalin
indol
amine
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018511333A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018515612A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/000783 external-priority patent/WO2016180536A1/en
Publication of JP2018515612A publication Critical patent/JP2018515612A/ja
Publication of JP2018515612A5 publication Critical patent/JP2018515612A5/ja
Pending legal-status Critical Current

Links

JP2018511333A 2015-05-13 2016-05-12 置換キノキサリン誘導体 Pending JP2018515612A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15001451.2 2015-05-13
EP15001451 2015-05-13
EP15460017.5 2015-05-13
EP15460017 2015-05-14
PCT/EP2016/000783 WO2016180536A1 (en) 2015-05-13 2016-05-12 Substituted quinoxaline derivatives

Publications (2)

Publication Number Publication Date
JP2018515612A JP2018515612A (ja) 2018-06-14
JP2018515612A5 true JP2018515612A5 (enExample) 2019-06-13

Family

ID=56081443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018511333A Pending JP2018515612A (ja) 2015-05-13 2016-05-12 置換キノキサリン誘導体

Country Status (9)

Country Link
US (1) US20180148429A1 (enExample)
EP (1) EP3294729A1 (enExample)
JP (1) JP2018515612A (enExample)
CN (1) CN107635986A (enExample)
AU (1) AU2016261031A1 (enExample)
CA (1) CA2979302A1 (enExample)
IL (1) IL254870A0 (enExample)
TW (1) TW201713641A (enExample)
WO (1) WO2016180536A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689647B (zh) * 2016-07-14 2023-01-20 百时美施贵宝公司 二环杂芳基取代的化合物
US20190256499A1 (en) 2016-11-08 2019-08-22 Merck Patent Gmbh Substituted quinoxaline derivatives as inhibitors of pfkfb
GB201705263D0 (en) * 2017-03-31 2017-05-17 Probiodrug Ag Novel inhibitors
WO2019065516A1 (ja) * 2017-09-26 2019-04-04 日本曹達株式会社 キノリン化合物および農園芸用殺菌剤
EP3737680A1 (en) 2018-01-08 2020-11-18 F. Hoffmann-La Roche AG Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors
HRP20230388T1 (hr) 2018-03-22 2023-06-23 F. Hoffmann - La Roche Ag Inhibitori oksazin monoacilglicerol lipaze (magl)
WO2019236884A1 (en) 2018-06-07 2019-12-12 Disarm Therapeutics, Inc. Inhibitors of sarm1
EP3837263B1 (en) 2018-08-13 2024-07-03 F. Hoffmann-La Roche AG New heterocyclic compounds as monoacylglycerol lipase inhibitors
EP3867226A4 (en) * 2018-10-15 2022-11-23 Gero Pte. Ltd. PFKFB3 INHIBITORS AND THEIR USES
EP3883936B1 (en) 2018-11-22 2023-07-12 F. Hoffmann-La Roche AG New heterocyclic compounds
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
CA3123215C (en) 2018-12-19 2024-04-02 Disarm Therapeutics, Inc. Inhibitors of sarm1 in combination with neuroprotective agents
WO2021026245A1 (en) * 2019-08-06 2021-02-11 The University Of North Carolina At Chapel Hill Rna-targeting ligands, compositions thereof, and methods of making and using the same
CN110698418B (zh) * 2019-09-11 2022-07-01 广西师范大学 一种3-芳胺基喹喔啉-2-甲酰胺类衍生物及其制备方法和应用
US11814375B2 (en) 2019-09-12 2023-11-14 Hoffmann-La Roche Inc. Heterocyclic compounds
MX2022003023A (es) 2019-09-23 2022-04-07 Hoffmann La Roche Compuestos heterociclicos.
US20240317753A9 (en) * 2020-05-08 2024-09-26 Merck Patent Gmbh Tricyclic heterocycles
IL300048A (en) * 2020-07-23 2023-03-01 Merck Patent Gmbh Heterocyclic compounds with three rings, their preparation and use
WO2022043284A1 (en) 2020-08-26 2022-03-03 F. Hoffmann-La Roche Ag Heterocyclic compounds useful as magl inhibitors
MX2023002224A (es) 2020-09-03 2023-03-15 Hoffmann La Roche Compuestos heterociclicos.
US20220169654A1 (en) 2020-11-25 2022-06-02 Servier Pharmaceuticals Llc New Organic Compounds
PH12023553248A1 (en) * 2021-06-02 2024-03-25 Univ North Carolina Chapel Hill Rna-targeting ligands, compositions thereof, and methods of making and using the same
EP4543870A1 (en) 2022-06-24 2025-04-30 F. Hoffmann-La Roche AG New heterocyclic-carbonyl-cyclic compounds as magl inhibitors
WO2025084787A1 (ko) * 2023-10-17 2025-04-24 가천대학교 산학협력단 신규 퀴녹살린 화합물, 이의 제조방법 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633218A (en) * 1995-05-24 1997-05-27 E. I. Du Pont De Nemours And Company Herbicidal benzodioxoles and benzodioxanes
US20140128392A1 (en) * 2009-03-19 2014-05-08 Bioenergenix Heterocyclic compounds for the inhibition of pask
WO2011103557A1 (en) * 2010-02-22 2011-08-25 Advanced Cancer Therapeutics, Llc Small molecule inhibitors of pfkfb3 and glycolytic flux and their methods of use as anti-cancer therapeutics
TW201311149A (zh) * 2011-06-24 2013-03-16 Ishihara Sangyo Kaisha 有害生物防治劑
CA2868787A1 (en) * 2012-03-29 2013-10-03 Advanced Cancer Therapeutics, Llc Pfkfb3 inhibitor and methods of use as an anti-cancer therapeutic

Similar Documents

Publication Publication Date Title
JP2018515612A5 (enExample)
JP7460593B2 (ja) サイクリン依存性キナーゼ7(cdk7)の阻害剤
US11130759B1 (en) 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
JP6117235B2 (ja) Pi3kの活性または機能の阻害剤の使用
JP6200520B2 (ja) 置換2−アミノピリジンプロテインキナーゼ阻害剤
ES2966457T3 (es) Derivados de pirazol como inhibidores de MALT1
TW201713641A (zh) 經取代之喹喏啉衍生物
JP2013501002A (ja) Sykキナーゼ阻害剤としての化合物および組成物
JP2015503504A (ja) ヘテロアリールおよびその使用
KR20160135283A (ko) 5-치환된 인다졸-3-카르복스아미드 및 이의 제조 및 용도
JP2013500972A (ja) Sykキナーゼ阻害剤としての2,7−ナフチリジン−1−オン誘導体
JP2013525498A5 (enExample)
MX2010008421A (es) Compuestos y composiciones como inhbidores de cinasa.
KR20130038420A (ko) 브루톤 티로신 키나아제의 억제제
CA2798622A1 (en) Indoles
AU2012318874A1 (en) 1,3-substituted azetidine PDE10 inhibitors
JP2010538094A (ja) チロシンキナーゼ阻害剤としてのピラゾロピリジン類
JP2023526841A (ja) ピペラジン環状尿素類
JP2025512957A (ja) Egfr阻害剤
TW202509019A (zh) Sarm1調節子、其製劑及用途
CA3245810A1 (en) PYRIDO[3,2-D]PYRIMIDINS USED AS HPK1 INHIBITORS
CN121586713A (zh) 用于治疗疾病的喹啉衍生物及其药物组合物
WO2024254490A1 (en) Pyrazolo-pyrimidinone compounds for use in methods of inhibiting wee1 a kinase
TW202115087A (zh) 作為第iii型受體酪胺酸激酶抑制劑之雜環吡唑衍生物
HK40012363A (en) Inhibitors of cyclin-dependent kinase 7 (cdk7)